Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

652
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
652
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

3.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.6K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

4.1K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.1K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

12.8K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
12.8K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

1.4K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.4K
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

106
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
106

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Baseline Tumor-Specific Prognosis in Early-Stage Hepatocellular Carcinoma: Time-Dependent Role of Biomarker Profile and Modified ALBI Grade.

Cancers·2026
Same author

Disability and race in MS: Does socioeconomic disadvantage play a role?

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

A new era for oral peptides: SNAC and the development of oral semaglutide for the treatment of type 2 diabetes.

Reviews in endocrine & metabolic disorders·2022
Same author

Editorial Cycles and Continuity of Diabetes Care.

Diabetes care·2022
Same author

Efficacy of liraglutide added to sodium-glucose cotransporter-2 inhibitors in type 2 diabetes, stratified by baseline characteristics: Post-hoc analysis of LIRA-ADD2SGLT2i.

Diabetes, obesity & metabolism·2021
Same author

Peak oxygen consumption achieved at the end of cardiac rehabilitation predicts long-term survival in patients with coronary heart disease.

European heart journal. Quality of care & clinical outcomes·2021

Related Experiment Video

Updated: Nov 2, 2025

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

12.0K

Improving Management of Type 2 Diabetes Using Home-Based Telemonitoring: Cohort Study.

Richard Milani1, Pavan Chava2, Jonathan Wilt1

  • 1Center for Health Innovation, Ochsner Health, New Orleans, LA, United States.

JMIR Diabetes
|June 10, 2021
PubMed
Summary

A virtual diabetes management program significantly improved glycemic control and reduced diabetes distress and hypoglycemic episodes in type 2 diabetes patients. This digital health intervention showed broad acceptance across diverse populations.

Keywords:
connected devicesdiabetesdigital healthdigital medicineehealth

More Related Videos

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.1K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.6K

Related Experiment Videos

Last Updated: Nov 2, 2025

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

12.0K
Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.1K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.6K

Area of Science:

  • Digital Health
  • Endocrinology
  • Clinical Informatics

Background:

  • Diabetes affects 10.5% of the US population, with office-based care often failing to prevent disease progression.
  • Adverse outcomes like poor glycemic control are common despite established medical approaches.
  • Home-based technology offers accurate data transmission to electronic medical records.

Purpose of the Study:

  • To evaluate the effectiveness of a virtual, home-based diabetes management program.
  • To compare clinical measures of diabetes control against usual care.

Main Methods:

  • A 1-year study comparing 763 type 2 diabetes patients in a digital medicine program with 794 usual care patients.
  • Digital program involved online questionnaires, remote recommendations from clinicians and health coaches, and Bluetooth glucose meter data transmission.
  • Patients were matched for key demographic and clinical characteristics.

Main Results:

  • Digital medicine patients showed significant improvements in hemoglobin A1c (HbA1c) levels (P<.001).
  • The proportion of patients with HbA1c ≥9.0% decreased significantly in the digital group (14% to 6%; P<.001).
  • Digital intervention also led to significant reductions in diabetes distress (26% to 16%; P<.001) and hypoglycemic episodes (41.1% to 11.9%; P<.001).

Conclusions:

  • A digital diabetes management program significantly improves glycemic control and other key diabetes metrics.
  • Virtual health interventions using connected devices are well-accepted across diverse patient populations.
  • This approach offers a viable strategy for enhancing diabetes care and outcomes.